These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 17583315)
1. Neurocognitive dysfunction post-cardiac surgery and the neuroprotective effects of erythropoietin. Bhimji Z; Estabrooks L; Price PM Can J Cardiovasc Nurs; 2007; 17(2):5-8; quiz 8-9, 5. PubMed ID: 17583315 [TBL] [Abstract][Full Text] [Related]
2. The erythropoietin neuroprotective effect: assessment in CABG surgery (TENPEAKS): a randomized, double-blind, placebo controlled, proof-of-concept clinical trial. Haljan G; Maitland A; Buchan A; Arora RC; King M; Haigh J; Culleton B; Faris P; Zygun D Stroke; 2009 Aug; 40(8):2769-75. PubMed ID: 19556536 [TBL] [Abstract][Full Text] [Related]
3. [Recent advances on the use of erythropoietin in oncology]. Spaëth D Bull Cancer; 2006 May; 93(5):489-93. PubMed ID: 16777627 [TBL] [Abstract][Full Text] [Related]
4. Intravenous iron following cardiac surgery does not increase the infection rate. Torres S; Kuo YH; Morris K; Neibart R; Holtz JB; Davis JM Surg Infect (Larchmt); 2006 Aug; 7(4):361-6. PubMed ID: 16978079 [TBL] [Abstract][Full Text] [Related]
5. Postoperative cognitive dysfunction after cardiac surgery. Gao L; Taha R; Gauvin D; Othmen LB; Wang Y; Blaise G Chest; 2005 Nov; 128(5):3664-70. PubMed ID: 16304328 [TBL] [Abstract][Full Text] [Related]
7. A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia. van Harten AE; Scheeren TW; Absalom AR Anaesthesia; 2012 Mar; 67(3):280-93. PubMed ID: 22321085 [TBL] [Abstract][Full Text] [Related]
13. Selection of neurocognitive tests and outcomes of cardiac surgery trials. Polunina AG Ann Thorac Surg; 2008 Jan; 85(1):362. PubMed ID: 18154859 [No Abstract] [Full Text] [Related]
14. Current readings: neurocognitive impairment and clinical implications after cardiac surgery. Tully PJ; Baker RA Semin Thorac Cardiovasc Surg; 2013; 25(3):237-44. PubMed ID: 24331146 [TBL] [Abstract][Full Text] [Related]
15. Hematopoietic management in oncology practice. Part 2. Erythropoietic factors. Glaspy JA Oncology (Williston Park); 2003 Dec; 17(12):1724-30; discussion 1731-2, 1735, 1739. PubMed ID: 14723012 [TBL] [Abstract][Full Text] [Related]
16. Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis. Hosono S; Hosono A; Mugishima H; Nakano Y; Minato M; Okada T; Takahashi S; Harada K Pediatr Int; 2006 Apr; 48(2):178-80. PubMed ID: 16635181 [No Abstract] [Full Text] [Related]
17. Response to letter regarding article, "Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery". Mathew JP; Laskowitz DT; Newman MF Stroke; 2014 Mar; 45(3):e45. PubMed ID: 24448987 [No Abstract] [Full Text] [Related]
18. C-Reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery. Ramlawi B; Rudolph JL; Mieno S; Feng J; Boodhwani M; Khabbaz K; Levkoff SE; Marcantonio ER; Bianchi C; Sellke FW Surgery; 2006 Aug; 140(2):221-6. PubMed ID: 16904973 [TBL] [Abstract][Full Text] [Related]
19. Embolism as major cause of neurocognitive complications after heart surgery. Tagarakis GI; Karangelis D; Tsolaki F; Tsilimingas NB Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):383. PubMed ID: 21345824 [No Abstract] [Full Text] [Related]
20. Erythropoiesis-stimulating agents in kidney and cardiac disease. Fluck R Br J Hosp Med (Lond); 2006 Oct; 67(10):533-7. PubMed ID: 17069130 [No Abstract] [Full Text] [Related] [Next] [New Search]